Skip to main content
. 2018 Feb 19;5(1):e000272. doi: 10.1136/bmjresp-2017-000272

Table 3.

Variables for aims 1, 2 and 3

Measure Data source Instrument timing Measurement psychometrics (# items)
Aim 1
 Demographics Age, gender, race and education Patient and caregiver Visit 1 Continuous and dichotomous
 Disease severity Forced vital capacity%, DLCO%, Oxygen yes/no, Date of diagnosis, Date of initial centre visit Patient Visit 1 Continuous and dichotomous
 Comorbidities # comorbidities Patient Visit 1 Chart review
 Feasibility Time, attendance Patient and caregiver All visits and study close Recruitment, retention rate
Aim 2 mediating variable
 Knowledge Patient and caregiver Visit 1 and 3 Continuous, 14 questions; supportive care Specific Content
 Acceptability of intervention Survey Patient and caregiver Study close Continuous
(Likert 1–10)
Aim 3 outcomes of intervention and evaluation
 Stress Stress Patient and caregiver PSS
Visit 1 and 3
14 items; Cronbach’s α: 0.89
 Symptom burden Physical function, anxiety, depression, fatigue, sleep quality, satisfaction with social role and pain Patient Patient Reported Outcome Measurement Information System-29
Visit 1 and 3
29 items; Cronbach’s α: 0.89–0.95
 Quality of life Quality of life Patient A Tool to Assess QOL in IPF
Visit 1 and 3
43 items; Psychometrics unavailable
 Disease preparedness Survey Patient and caregiver 0–10 scale
 Advanced care planning (ACP) completion ACP Patient and caregiver Visit 3 Two items (yes or no)
Patient completed >50% ACP yes/no
At study close
 QODD (if patient deceased) Quality of dying and death Caregiver After patient death 14 items; Cronbach’s α: 0.89
 End of life care trajectory Chart Review Survey Chart At study close Formal palliative care
Referral, intensive care unit admission, location of death